id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-N-6716-0001,FDA,FDA-2017-N-6716,New Insights for Product Development and Bioequivalence Assessments of Generic Orally Inhaled and Nasal Drug Products; Public Workshop; Request for Comments,Notice,Announcement,2017-12-19T05:00:00Z,2017,12,2017-12-19T05:00:00Z,2018-02-15T04:59:59Z,2018-02-15T02:03:48Z,2017-27279,0,0,0900006482d3ae6f